| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Breast Cancer as a World Challenge
|
Sledge Jr., George W.
|
|
2004
|
5 |
1 |
p. 11-
1 p.
|
article
|
| 2 |
Conservative Management of Breast Cancer in BRCA1/2 Mutation Carriers
|
Alpert, Tracy E.
|
|
2004
|
5 |
1 |
p. 37-42
6 p.
|
article
|
| 3 |
Continuation of Trastuzumab Beyond Disease Progression: More Questions Than Answers
|
Razis, Evangelia
|
|
2004
|
5 |
1 |
p. 59-62
4 p.
|
article
|
| 4 |
HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues
|
Owens, Marilyn A.
|
|
2004
|
5 |
1 |
p. 63-69
7 p.
|
article
|
| 5 |
2003 Highlights from: 26th Annual San Antonio Breast Cancer Symposium San Antonio, Texas, December 2003
|
Reddy, G. Kesava
|
|
2004
|
5 |
1 |
p. 22-28
7 p.
|
article
|
| 6 |
How Important Is HER2/neu Amplification and Expression when Selecting Patients for HER2/neu–Targeted Therapies?
|
Davol, Pamela A.
|
|
2004
|
5 |
1 |
p. 70-71
2 p.
|
article
|
| 7 |
Management of T1a Breast Cancer
|
Kiel, Krystyna D.
|
|
2004
|
5 |
1 |
p. 43-51
9 p.
|
article
|
| 8 |
Outcome After Treatment of Patients with Mammographically Occult, Magnetic Resonance Imaging—Detected Breast Cancer Presenting with Axillary Lymphadenopathy
|
Chen, Changhu
|
|
2004
|
5 |
1 |
p. 72-77
6 p.
|
article
|
| 9 |
Use of Aromatase Inhibitors in the Adjuvant Setting: The “Switching” Trials
|
Tyagi, Preeta
|
|
2004
|
5 |
1 |
p. 31-34
4 p.
|
article
|
| 10 |
Use of Trastuzumab Beyond Disease Progression: Observations from a Retrospective Review of Case Histories
|
Gelmon, Karen A.
|
|
2004
|
5 |
1 |
p. 52-58
7 p.
|
article
|
Journal description